Clinical Research Directory
Browse clinical research sites, groups, and studies.
Perioperative Hemostasis Management in Liver Transplantation
Sponsor: Société Française d'Anesthésie et de Réanimation
Summary
Liver transplantation (LT) is a surgery with risk of bleeding. Several risk factors have been identified: complex dissection, portal hypertension, history of ascites fluid infections, history of surgical procedures, pre-existing complex hemostatic disorders and those acquired during the procedure. Diffuse bleeding can occur at any time during the 3 phases of surgery: dissection, anhepatic and neohepatic. However, intraoperative bleeding and transfusion requirements remain difficult to predict. Current predictive models are based in particular on preoperative characteristics and do not take into account the course and different phases of the operation. The need for transfusions has largely decreased over the last 20 years, and currently around 20-25% of patients are transfused (transfusion of at least 1 blood product during LT). However, massive transfusion is necessary in 10% of LT. The European Society of Anaesthesiology (ESA) has issued recommendations on the management of severe bleeding during surgery. However, these recommendations are not specific to LT. Moreover, transfusion strategies vary widely from one center to another. The implementation of protocols within teams dedicated to LT has led to a reduction in bleeding and transfusion, with or without the use of viscoelastic testing. Intraoperative bleeding and transfusion requirements, as well as postoperative thromboembolic complications, remain difficult to predict. Predictive models of bleeding risk have been developed, but they are based solely on preoperative characteristics and do not take into account the course and various phases of the operation. In addition, new methods such as Bayesian inference or machine learning have been developed, and seem capable of providing different information from that obtained by conventional models. The overall aim of this prospective multicenter observational study is to investigate the risk factors for bleeding and thrombosis in per- and post-operative LT using different predictive methods, and to describe the management of bleeding and post-operative anticoagulation in metropolitan France.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1200
Start Date
2024-10-17
Completion Date
2026-12-31
Last Updated
2026-04-02
Healthy Volunteers
No
Conditions
Locations (16)
Chru Minjoz
Besançon, France
CHU Estaing
Clermont, France
Hôpital Beaujon
Clichy, France
CHU Grenoble Alpes
Grenoble, France
CHU Claude Huriez
Lille, France
Hôpital de la Croix-Rousse
Lyon, France
CHU La Timone
Marseille, France
Hôpital St Eloi
Montpellier, France
Hôpital De L'Archet 2
Nice, France
CHU Pitié-Salpêtrière
Paris, France
CHU Haut Levêque
Pessac, France
CHU Pontchaillou
Rennes, France
CHU Hautepierre
Strasbourg, France
CHU Toulouse Rangueil
Toulouse, France
CHU Tours
Tours, France
Hôpital Paul Brousse
Villejuif, France